Clinical Trial

The SAM Project: Science Against Malnutrition Project

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 4, 2025 (before its estimated July 24, 2026 completion). Its status may not reflect the trial's current state.
Summary
The latest data from the World Health Organization (WHO) shows that malnutrition in all its forms affects over 2.5 billion people globally. This condition is constantly increasing and affects the entire population, from childhood to the elderly. Malnutrition in all its forms negatively impacts the quality of life of patients affected and increases the risk of morbidity and mortality, as well as healthcare costs. Considering the complexity and multifactorial nature of malnutrition, the integration of multi-omics data obtained from analyzes with high-throughput technologies such as epigenomics, metagenomics, metabolomics, could benefit the prediction and evaluation of prognosis and/or response to specific treatments; this could pave the way for personalized precision medicine interventions for patients suffering from malnutrition. The SAM study aims to characterize malnutrition through the identification of specific biomarkers of the condition with the aim of developing innovative prevention and treatment programs.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-11-22.
Trial Details
NCT Number NCT06152848
Lead Sponsor Federico II University
Conditions Malnutrition
Enrollment 2,000 participants
Start Date 2023-07-24
Primary Completion 2026-07-24 (estimated)
Study Completion 2026-07-24 (estimated)
Updated on ClinicalTrials.gov 2025-06-04